Sign in

CIK 0001674416 · Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
operating
EIN
473173478
Phone
6173154600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Kulkarni Samarth −$2.6M Chief Executive Officer sold 14% of stake
  2. KASINGER JAMES R. −$797K General Counsel and Secretary sold 12% of stake
  3. Behbahani Ali −$781K Director sold 45% of stake
  4. George Simeon −$720K Director sold 48% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-03-11 KASINGER JAMES R. General Counsel and Secretary Option exercise +2,250 47,468
2022-03-11 KASINGER JAMES R. General Counsel and Secretary Option exercise · Restricted Stock Units −2,250 6,750
2022-03-10 Kulkarni Samarth Chief Executive Officer Option exercise +11,834 290,919
2022-03-10 Kulkarni Samarth Chief Executive Officer Option exercise · Restricted Stock Units −11,834 11,833
2022-03-10 Klein Lawrence Otto CBO & COO Option exercise +4,584 26,909
2022-03-10 Klein Lawrence Otto CBO & COO Option exercise · Restricted Stock Units −4,584 4,583
2022-03-10 KASINGER JAMES R. General Counsel and Secretary Option exercise +2,834 46,539
2022-03-10 KASINGER JAMES R. General Counsel and Secretary Option exercise · Restricted Stock Units −2,834 2,833
2022-02-18 Smith Brendan Chief Financial Officer Grant or award · Stock Option (Right to Buy) +30,000 30,000
2022-02-18 Smith Brendan Chief Financial Officer Grant or award · Restricted Stock Units +15,300 15,300
2022-02-18 Kulkarni Samarth Chief Executive Officer Grant or award · Stock Option (Right to Buy) +115,000 115,000
2022-02-18 Kulkarni Samarth Chief Executive Officer Grant or award · Restricted Stock Units +53,000 53,000
2022-02-18 Klein Lawrence Otto CBO & COO Grant or award · Stock Option (Right to Buy) +46,200 46,200
2022-02-18 Klein Lawrence Otto CBO & COO Grant or award · Restricted Stock Units +20,400 20,400
2022-02-18 KASINGER JAMES R. General Counsel and Secretary Grant or award · Stock Option (Right to Buy) +34,200 34,200
2022-02-18 KASINGER JAMES R. General Counsel and Secretary Grant or award · Restricted Stock Units +15,300 15,300
2021-12-20 Kulkarni Samarth Chief Executive Officer Option exercise +17,750 $1.81 $32K 279,085
2021-12-20 Kulkarni Samarth Chief Executive Officer Option exercise · Stock Option (Right to Buy) −17,750 58,233
2021-12-06 Kulkarni Samarth Chief Executive Officer Shares withheld for taxes −37,818 $69.17 $2.6M 261,335
2021-12-06 Klein Lawrence Otto CBO & COO Shares withheld for taxes −11,185 $69.17 $774K 22,325

Page 23 of 46 · 910 trades